Published in Eur J Neurosci on November 20, 2006
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther (2009) 1.67
Animal models of schizophrenia. Br J Pharmacol (2011) 1.60
Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology (2011) 1.19
Social influences on neurobiology and behavior: epigenetic effects during development. Psychoneuroendocrinology (2010) 1.11
Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. Neuropsychopharmacology (2011) 1.06
Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. Psychopharmacology (Berl) (2007) 1.03
The zinc dyshomeostasis hypothesis of Alzheimer's disease. PLoS One (2012) 1.02
The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat. Psychopharmacology (Berl) (2010) 1.01
Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats. Eur J Neurosci (2013) 1.00
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) (2011) 0.99
Neural cytoskeleton capabilities for learning and memory. J Biol Phys (2010) 0.93
Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behav Brain Res (2010) 0.88
Models of neurodevelopmental abnormalities in schizophrenia. Curr Top Behav Neurosci (2010) 0.88
Voluntary Ethanol Consumption Induced by Social Isolation Reverses the Increase of α(4)/δ GABA(A) Receptor Gene Expression and Function in the Hippocampus of C57BL/6J Mice. Front Neurosci (2011) 0.87
Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats. Psychopharmacology (Berl) (2010) 0.86
Insights into plant consciousness from neuroscience, physics and mathematics: a role for quasicrystals? Plant Signal Behav (2012) 0.85
Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC. Psychopharmacology (Berl) (2011) 0.85
Perceived social isolation, evolutionary fitness and health outcomes: a lifespan approach. Philos Trans R Soc Lond B Biol Sci (2015) 0.84
Post-weaning social isolation impairs observational fear conditioning. Behav Brain Res (2013) 0.84
3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders. Proc Natl Acad Sci U S A (2012) 0.83
Captivity reduces hippocampal volume but not survival of new cells in a food-storing bird. Dev Neurobiol (2009) 0.83
Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development. Clin Schizophr Relat Psychoses (2010) 0.83
MSK1 regulates environmental enrichment-induced hippocampal plasticity and cognitive enhancement. Learn Mem (2012) 0.82
Isolation rearing effects on probabilistic learning and cognitive flexibility in rats. Cogn Affect Behav Neurosci (2014) 0.82
Adolescent social isolation changes social recognition in adult mice. Behav Brain Res (2010) 0.82
Enhanced Sensitivity to Ethanol-Induced Inhibition of LTP in CA1 Pyramidal Neurons of Socially Isolated C57BL/6J Mice: Role of Neurosteroids. Front Endocrinol (Lausanne) (2011) 0.81
The atypical antipsychotic risperidone reverses the recognition memory deficits induced by post-weaning social isolation in rats. Psychopharmacology (Berl) (2013) 0.80
Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia. Int J Neuropsychopharmacol (2016) 0.78
Pharmacological characterization of social isolation-induced hyperactivity. Psychopharmacology (Berl) (2010) 0.78
Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat. Psychopharmacology (Berl) (2014) 0.77
Effects of the Synthetic Neurosteroid: 3β-Methoxypregnenolone (MAP4343) on Behavioral and Physiological Alterations Provoked by Chronic Psychosocial Stress in Tree Shrews. Int J Neuropsychopharmacol (2016) 0.76
Effect of agomelatine on memory deficits and hippocampal gene expression induced by chronic social defeat stress in mice. Sci Rep (2017) 0.75
Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine. Cogn Affect Behav Neurosci (2015) 0.75
Hypothalamic gastrin-releasing peptide receptor mediates an antidepressant-like effect in a mouse model of stress. Am J Transl Res (2016) 0.75
Stress and adolescent hippocampal neurogenesis: diet and exercise as cognitive modulators. Transl Psychiatry (2017) 0.75
Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice. Psychopharmacology (Berl) (2015) 0.75
Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev (1975) 1.79
In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem (1983) 1.60
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J Pharmacol Exp Ther (2000) 1.56
Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function. Q J Exp Psychol B (1986) 1.53
Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res (1999) 1.45
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
Anxiogenic-like effects of chronic cannabidiol administration in rats. Psychopharmacology (Berl) (2011) 1.44
Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function. J Neurochem (1998) 1.43
Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res (2001) 1.42
A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). J Med Chem (2000) 1.42
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. Br J Pharmacol (2008) 1.32
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry (2009) 1.22
Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neurosci Behav Physiol (2003) 1.22
Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems. Ann N Y Acad Sci (2001) 1.21
Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J Neuroendocrinol (2006) 1.19
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology (2003) 1.17
Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems. Pharmacol Biochem Behav (1998) 1.15
Voltammetry in brain tissue: chronic recording of stimulated dopamine and 5-hydroxytryptamine release. Life Sci (1978) 1.15
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
The behavioural effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology (Berl) (1998) 1.11
A comparison of rectal and subcutaneous body temperature measurement in the common marmoset. J Pharmacol Toxicol Methods (1998) 1.10
Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology (Berl) (2000) 1.09
Resocialisation of isolation-reared rats does not alter their anxiogenic profile on the elevated X-maze model of anxiety. Physiol Behav (1991) 1.08
Differential role of the medial and lateral prefrontal cortices in fear and anxiety. Behav Neurosci (2000) 1.08
Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation. J Neurosci Methods (1995) 1.08
Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry. Pharmacol Biochem Behav (1992) 1.07
Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. Neuropharmacology (1999) 1.06
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
Social isolation increases aggressive behaviour and alters the effects of diazepam in the rat social interaction test. Behav Brain Res (1996) 1.05
Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience (2005) 1.01
Selective responding of nucleus accumbens core and shell dopamine to aversively conditioned contextual and discrete stimuli. Neuroscience (2001) 1.00
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology (2001) 0.99
Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats. Br J Pharmacol (1999) 0.98
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci (2004) 0.97
Reaction of gadolinium chelates with endogenously available ions. Magn Reson Imaging (1991) 0.97
5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism. Neuropharmacology (2004) 0.97
The involvement of 5-hydroxytryptamine and dopamine in the behavioural effects of alpha-methyltryptamine [proceedings]. Br J Pharmacol (1978) 0.96
(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist. J Med Chem (1998) 0.96
[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors. Br J Pharmacol (2000) 0.95
Effects of chronic modification of dietary fat and carbohydrate in rats. Biochem J (1981) 0.95
Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens. Psychopharmacology (Berl) (1990) 0.93
Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates. Behav Brain Res (1991) 0.93
Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Br J Pharmacol (1986) 0.93
The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan. Neuropharmacology (1979) 0.93
Neuronal plasticity, stress and depression: involvement of the cytoskeletal microtubular system? Curr Drug Targets CNS Neurol Disord (2005) 0.92
Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berl) (1992) 0.92
Alterations in core body temperature, locomotor activity, and corticosterone following acute and repeated social defeat of male NMRI mice. Physiol Behav (2001) 0.92
Central c-fos expression following 20kHz/ultrasound induced defence behaviour in the rat. Brain Res Bull (1997) 0.92
Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology (Berl) (2005) 0.91
A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regul Pept (1984) 0.91
Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse. Psychopharmacology (Berl) (2003) 0.91
Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology (Berl) (1983) 0.91
Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats. Psychopharmacology (Berl) (2005) 0.90
Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats. J Psychopharmacol (2001) 0.90
Decreased GABA release following tonic-clonic seizures is associated with an increase in extracellular glutamate in rat hippocampus in vivo. Neuroscience (1995) 0.90
Feeding rats on diets rich in fat need not alter the concentrations of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain. Biochem J (1982) 0.90
Changes in monoamine metabolites measured by simultaneous in vivo differential pulse voltammetry and intracerebral dialysis. Neuroscience (1984) 0.89
Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl) (2001) 0.89
Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res (1979) 0.89
5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl) (2001) 0.89
Increased responsiveness to 5-methoxy-N,N-dimethyltryptamine in mice on a high tryptophan diet. Neuropharmacology (1979) 0.89
Effects of lesions and drugs on brain tryptamine. J Neurochem (1974) 0.89
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl) (2001) 0.89
Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. Psychopharmacology (Berl) (2001) 0.89
Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. Br J Pharmacol (1996) 0.89
Measurement of arginase activity. Anal Biochem (1968) 0.88
The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo. Br J Pharmacol (1985) 0.88
In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Brain Res (1990) 0.87
Effect of isolation-rearing on conditioned dopamine release in vivo in the nucleus accumbens of the rat. J Neurochem (1998) 0.87
Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test. Behav Brain Res (2000) 0.87
Comparative studies of brain 5-hydroxytryptamine and tryptamine. Adv Biochem Psychopharmacol (1974) 0.87
Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze. Psychopharmacology (Berl) (2001) 0.87
Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetized rat. Neuropharmacology (1984) 0.87
Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis. Neuropharmacology (2010) 0.87
Measurement of extracellular basal levels of serotonin in vivo using nafion-coated carbon fibre electrodes combined with differential pulse voltammetry. Neuroscience (1988) 0.87
Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology (2003) 0.86
Substrate recognition mechanism of prolyl aminopeptidase from Serratia marcescens. J Biochem (2000) 0.86
Dopamine D2 receptor stimulation inhibits cold-initiated thermogenesis in brown adipose tissue in conscious rats. Neuroscience (2007) 0.86
Central noradrenergic depletion by DSP-4 prevents stress-induced memory impairments in the object recognition task. Neuroscience (2009) 0.86
Location and release of TRH and 5-HT from amphibian skin. Cell Biol Int Rep (1981) 0.86
Localization and release of 5-hydroxytryptamine thyrotrophin releasing hormone and substance P in rat ventral spinal cord. Comp Biochem Physiol C (1982) 0.86
Metabolism of a tryptophan load in the hypothalamus and other brain regions. J Neurochem (1975) 0.85
The effects of monoamine neurotoxins on peptides in the rat spinal cord. Neuroscience (1982) 0.85
Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing. J Psychopharmacol (2011) 0.85
Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats. Br J Pharmacol (1989) 0.85
Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum. Behav Processes (2005) 0.85
Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience (2000) 0.85
Effects of the A 2A adenosine receptor antagonist KW6002 in the nucleus accumbens in vitro and in vivo. Pharmacol Biochem Behav (2006) 0.84
Isolation rearing in the rat disrupts the hippocampal response to stress. Neuroscience (2002) 0.84
Reduced synaptophysin immunoreactivity in the dentate gyrus of prepulse inhibition-impaired isolation-reared rats. Brain Res (1999) 0.84
Catecholaminergic depletion within the prelimbic medial prefrontal cortex enhances latent inhibition. Neuroscience (2010) 0.84
Conditioned dopamine release: dependence upon N-methyl-D-aspartate receptors. Neuroscience (1995) 0.84
Fluorescent microscopy of the 5HT- and catecholamine-containing cells in the central nervous system of the leech Hirudo medicinalis. Comp Biochem Physiol (1969) 0.84
Effects of cocaine on dopamine in subregions of the rat prefrontal cortex and their efferents to subterritories of the nucleus accumbens. Eur J Pharmacol (1999) 0.84